Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEP4LEP chemoprophylaxis for leprosy: skin camp versus health centre-based contact screening
PACTR202303742093429Recruiting
- Sponsor
- NLR Bio
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Open-label trial of rifampicin in leprosy (HD) (2 arms), sponsored by NLR Bio. Started Oct 2018; status: recruiting.
02
Drugs
rifampicin
03
Conditions
leprosy (HD)
Beyond the preview
Go deeper on PACTR202303742093429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202303742093429.